- Home
- MNRO vs ARCT Comparison
MNRO vs ARCT Comparison
Compare MNRO & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNRO | ARCT |
|---|---|---|
| Founded | 1957 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 443.3M | 369.5M |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MNRO | ARCT |
|---|---|---|
| Price | $13.70 | $13.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 13 |
| Target Price | $22.00 | ★ $23.20 |
| AVG Volume (30 Days) | ★ 814.6K | 780.8K |
| Earning Date | 10-28-2026 | 11-09-2026 |
| Dividend Yield | ★ 8.15% | N/A |
| EPS Growth | ★ 113.64 | 20.00 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $1,157,176,000.00 | $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.98 | $58.72 |
| P/E Ratio | $458.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.06 | $5.50 |
| 52 Week High | $23.91 | $24.14 |
Technical Indicators
Market Signals| Indicator | MNRO | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 50.44 |
| Support Level | $12.01 | $13.12 |
| Resistance Level | $14.27 | $17.85 |
| Average True Range (ATR) | 0.54 | 1.12 |
| MACD | 0.01 | -0.27 |
| Stochastic Oscillator | 47.54 | 53.18 |
Price Performance
Historical ComparisonAbout MNRO Monro Inc.
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.